Afterward, patients were evaluated by SPECT imaging and UPRDS (Unified Parkinson’s Disease Rating Scale) score, which showed that NAC improved dopamine transporter (DAT) binding in PD patients, correlating with improvement symptoms [131]. Here, SLC6A3 is linked to Parkinson disease.